Perception and Experience of Dupilumab in Atopic Dermatitis: A Real-Life Study.
Léa AntoineEve PuzenatDragos PopescuRomain CharollaisFlora DrescoAnne-Sophie DupondDominique SalardMarie-Christine Drobacheff-ThiebautAnaïs ZanellaAnne DucournauIréne Gallais-SerezalFrançois AubinPublished in: Patient preference and adherence (2023)
Although AD treatments may contribute to the burden of the disease, dupilumab was associated with a lower burden score, likely reflecting both treatment efficacy and easy of use and patient satisfaction.
Keyphrases